Terms: = Bone cancer AND CARS, P49589, 833, ENSG00000110619 AND Treatment
46 results:
1. A grayscale compression method to segment bone structures for 2D-3D registration of setup images in non-coplanar radiotherapy.
Song Z; Li T; Zuo L; Song Y; Wei R; Dai J
Biomed Phys Eng Express; 2024 Mar; 10(3):. PubMed ID: 38442730
[No Abstract] [Full Text] [Related]
2. Ct-based intratumoral and peritumoral radiomics for predicting prognosis in osteosarcoma: A multicenter study.
Su Q; Wang N; Wang B; Wang Y; Dai Z; Zhao X; Li X; Li Q; Yang G; Nie P
Eur J Radiol; 2024 Mar; 172():111350. PubMed ID: 38309216
[TBL] [Abstract] [Full Text] [Related]
3. Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review).
Kausar MA; Anwar S; El-Horany HE; Khan FH; Tyagi N; Najm MZ; Sadaf ; Eisa AA; Dhara C; Gantayat S
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37830150
[TBL] [Abstract] [Full Text] [Related]
4. Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice.
Pfeifer R; Al Rawashdeh W; Brauner J; Martinez-Osuna M; Lock D; Herbel C; Eckardt D; Assenmacher M; Bosio A; Hardt OT; Johnston ICD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298141
[TBL] [Abstract] [Full Text] [Related]
5. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours.
Flugel CL; Majzner RG; Krenciute G; Dotti G; Riddell SR; Wagner DL; Abou-El-Enein M
Nat Rev Clin Oncol; 2023 Jan; 20(1):49-62. PubMed ID: 36418477
[TBL] [Abstract] [Full Text] [Related]
6. Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis.
Liu Z; Liu H; Wang D
Sci Rep; 2022 Oct; 12(1):18085. PubMed ID: 36302941
[TBL] [Abstract] [Full Text] [Related]
7. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract] [Full Text] [Related]
8. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Liu AJ; Kosiorek HE; Ueberroth BE; Jaeger E; Ledet E; Kendi AT; Tzou K; Quevedo F; Choo R; Moore CN; Ho TH; Singh P; Keole SR; Wong WW; Sartor O; Bryce AH
Prostate; 2022 Sep; 82(12):1202-1209. PubMed ID: 35652618
[TBL] [Abstract] [Full Text] [Related]
9. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
Talleur AC; Qudeimat A; Métais JY; Langfitt D; Mamcarz E; Crawford JC; Huang S; Cheng C; Hurley C; Madden R; Sharma A; Suliman A; Srinivasan A; Velasquez MP; Obeng EA; Willis C; Akel S; Karol SE; Inaba H; Bragg A; Zheng W; Zhou SM; Schell S; Tuggle-Brown M; Cullins D; Patil SL; Li Y; Thomas PG; Zebley C; Youngblood B; Pui CH; Lockey T; Geiger TL; Meagher MM; Triplett BM; Gottschalk S
Blood Adv; 2022 Nov; 6(21):5737-5749. PubMed ID: 35446934
[TBL] [Abstract] [Full Text] [Related]
10. Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy.
An L; Lin Y; Deng B; Yin Z; Zhao D; Ling Z; Wu T; Zhao Y; Chang AH; Tong C; Liu S
BMC Cancer; 2022 Apr; 22(1):393. PubMed ID: 35410148
[TBL] [Abstract] [Full Text] [Related]
11. B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.
Zhang S; Black RG; Kohli K; Hayes BJ; Miller C; Koehne A; Schroeder BA; Abrams K; Schulte BC; Alexiev BA; Heimberger AB; Zhang A; Jing W; Ng JCK; Shinglot H; Seguin B; Salter AI; Riddell SR; Jensen MC; Gottschalk S; Moore PF; Torok-Storb B; Pollack SM
Mol Cancer Ther; 2022 Jun; 21(6):999-1009. PubMed ID: 35405743
[TBL] [Abstract] [Full Text] [Related]
12. Cost-Effectiveness of treatment Strategies for Spinal Metastases.
Kowalchuk RO; Mullikin TC; Kim DK; Morris JM; Ebner DK; Harmsen WS; Merrell KW; Beriwal S; Waddle MR; Kim H
Pract Radiat Oncol; 2022; 12(3):236-244. PubMed ID: 35045365
[TBL] [Abstract] [Full Text] [Related]
13. Circulating tumor cells in patients undergoing androgen deprivation therapy with versus without cryosurgery for metastatic prostate cancer: a retrospective analysis.
Sheng M; Guo S; Liu C
World J Surg Oncol; 2021 Dec; 19(1):345. PubMed ID: 34903228
[TBL] [Abstract] [Full Text] [Related]
14. CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial.
Cordoba S; Onuoha S; Thomas S; Pignataro DS; Hough R; Ghorashian S; Vora A; Bonney D; Veys P; Rao K; Lucchini G; Chiesa R; Chu J; Clark L; Fung MM; Smith K; Peticone C; Al-Hajj M; Baldan V; Ferrari M; Srivastava S; Jha R; Arce Vargas F; Duffy K; Day W; Virgo P; Wheeler L; Hancock J; Farzaneh F; Domning S; Zhang Y; Khokhar NZ; Peddareddigari VGR; Wynn R; Pule M; Amrolia PJ
Nat Med; 2021 Oct; 27(10):1797-1805. PubMed ID: 34642489
[TBL] [Abstract] [Full Text] [Related]
15. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract] [Full Text] [Related]
16. Taking a BiTE out of the CAR T space race.
Patel A; Oluwole O; Savani B; Dholaria B
Br J Haematol; 2021 Dec; 195(5):689-697. PubMed ID: 34131894
[TBL] [Abstract] [Full Text] [Related]
17. Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.
Poels R; Drent E; Lameris R; Katsarou A; Themeli M; van der Vliet HJ; de Gruijl TD; van de Donk NWCJ; Mutis T
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499253
[TBL] [Abstract] [Full Text] [Related]
18. Allogeneic CAR Cell Therapy-More Than a Pipe Dream.
Caldwell KJ; Gottschalk S; Talleur AC
Front Immunol; 2020; 11():618427. PubMed ID: 33488631
[TBL] [Abstract] [Full Text] [Related]
19. Society for Immunotherapy of cancer (SITC) clinical practice guideline on immune effector cell-related adverse events.
Maus MV; Alexander S; Bishop MR; Brudno JN; Callahan C; Davila ML; Diamonte C; Dietrich J; Fitzgerald JC; Frigault MJ; Fry TJ; Holter-Chakrabarty JL; Komanduri KV; Lee DW; Locke FL; Maude SL; McCarthy PL; Mead E; Neelapu SS; Neilan TG; Santomasso BD; Shpall EJ; Teachey DT; Turtle CJ; Whitehead T; Grupp SA
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335028
[TBL] [Abstract] [Full Text] [Related]
20. Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight.
Land CA; Musich PR; Haydar D; Krenciute G; Xie Q
J Transl Med; 2020 Nov; 18(1):428. PubMed ID: 33176788
[TBL] [Abstract] [Full Text] [Related]
[Next]
